Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.91% shed 0.31% to $166.58 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.47% falling 0.97% to 4,532.76 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% falling 0.96% to 35,028.65. This was the stock's seventh consecutive day of losses. Johnson & Johnson closed $13.34 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.41% rose 0.82% to $398.68, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.83% fell 0.31% to $81.29, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.15% fell 1.05% to $53.54. Trading volume (5.9 M) remained 1.6 million below its 50-day average volume of 7.5 M.